Becker's Healthcare March 1, 2023
Noah Schwartz

Artificial intelligence-powered precision medicine company Tempus is partnering with pharmaceutical giant Pfizer on a project aiming to advance the use of AI and machine learning capabilities in oncology therapeutic discovery.

Through the partnership, Tempus will grant Pfizer access to its data library, diagnostic offerings and clinical trial matching program, according to a Feb. 28 Tempus news release.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Partnerships, Pharma, Pharma / Biotech, Precision Medicine, Technology, Trends
23andMe: What If …
23andMe CEO Anne Wojcicki considers taking company private
Age of Opportunity: Artificial Intelligence and the Precision Medicine Future
Opinion: Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and more
Precision medicine approach combining AI, DNA and drug testing shows gains against relapsed childhood cancers

Share This Article